Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Astellas Pharma Europe Ltd - Putting the patient first: Considering treatment choice and maximising quality of life in mHSPC

Closing remarks

Date

22 Oct 2023

Session

Astellas Pharma Europe Ltd - Putting the patient first: Considering treatment choice and maximising quality of life in mHSPC

Topics

Tumour Site

Prostate Cancer

Presenters

Christopher Sweeney

Authors

C. Sweeney

Author affiliations

  • South Australian Immunogenomics Cancer Institute, The University of Adelaide, 5005 - Adelaide/AU

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: Christopher Sweeney

Session: Astellas Pharma Europe Ltd - Putting the patient first: Considering treatment choice and maximising quality of life in mHSPC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.